|
Self-Scored Cardiovascular Disease Risk Appraisal Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Self-Scored Cardiovascular Disease Risk Appraisal conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Self-Scored Cardiovascular Disease Risk Appraisal Clinical research trials and Self-Scored Cardiovascular Disease Risk Appraisal healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Self-Scored Cardiovascular Disease Risk Appraisal. Self-Scored Cardiovascular Disease Risk Appraisal Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Self-Scored Cardiovascular Disease Risk Appraisal clinical trial. Subjects frequently obtain the most expert healthcare possible for their Self-Scored Cardiovascular Disease Risk Appraisal condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Self-Scored Cardiovascular Disease Risk Appraisal  Self-Scored Cardiovascular Disease Risk Appraisal
Self-Scored Cardiovascular Disease Risk Appraisal
For Condition: Cardiovascular Diseases,Coronary Heart Disease Risk Reduction,Heart Diseases
Status: Completed
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To develop and test a self-scored cardiovascular disease health risk appraisal.
Details: BACKGROUND: Health risk appraisals (HRA) are being used increasingly by health centers and worksites to inform people of their personal mortality and morbidity risks. However, recent research suggests that many HRAs have limited reliability and validity with respect to coronary heart disease, the leading cause of death in this country. Self-scored HRAs appear to be considerably less accurate in predicting CHD risk than computerized instruments, chiefly because people do not always know the physiologic values required by these instruments and because they frequently make errors computing their scores. DESIGN NARRATIVE: During Phase I, a new appraisal named CardioRisk was developed. The Phase I prototype version contained eight major self-reported risk factors. CardioRisk predicted the risk of developing cardiovascular disease (CVD) in a 12-year period using an equation based on recent accelerated failure time models from the Framingham Heart Study. The purpose of Phase II was to thoroughly test and refine the prototype instrument. The Phase II analyses were designed to assess the psychometric properties of CardioRisk, to evaluate its utility as judged by patients, and to determine whether the instrument changed perceptions of personal CVD risk. These results were compared to data for other appraisals to determine whether CardioRisk outperformed comparable products. In the proposed commercial application, CardioRisk would be distributed by health promotion organizations to increase awareness of the risk factors for cardiovascular disease. Estimates from the American Heart Association put the demand for these products at 180,000 HRAs per year. The potential market for this product includes worksites, community health centers, managed health care organizations, public health departments, and clinics.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Male
Protocol Entry Criteria: No eligibility criteria
Total Enrollment:
Location and Contact Information:
Additional Information:
Study ID Numbers: 5062;
Study Start Date: September 1995
Record last reviewed: November 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00005529
Other Coronary Heart Disease Risk Reduction Studies:
1. Providers for Smoking Prevention Programs
2. Community Site Coronary Risk Control in Black Families
3. Study of Children's Activity and Nutrition (SCAN)--Extended Analyses
4. Fat Reduction Intervention Trial in African-Americans
5. Trial of Smoking Cessation Programs in Black Churches
Related Studies:
Other Coronary Heart Disease Risk Reduction Clinical Trials
Other Clinical Trials
Other Clinical Trials
Self-Scored Cardiovascular Disease Risk Appraisal
|
|
|
|
|
|
|
|
